Healthcare Transactions in Massachusetts: What Investors Should Know

Please join healthcare regulatory and transactions attorneys Julia Hesse and John Saran from Holland & Knight and Massachusetts Health Policy Commission (HPC) General Counsel Lois Johnson for a highly informative conversation about the regulatory review processes for healthcare transactions in Massachusetts.

Topics include:

• key aspects of House Bill 5159, the recent statute that updated Massachusetts Cost and Market Impact Review requirements
• guidance and issuance of regulation implementing the revised statutory requirements
• HPC insights on the updated requirements and practical takeaways or lessons from previously reviewed transactions
• discussion comparing Massachusetts' established transaction review process to other states that have more recently passed similar legislation

We hope you can join us for this engaging discussion that will provide an opportunity to hear directly from HPC and engage in a Q&A session.